Company Comparison
FibroGen vs BioAnalytics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | FibroGen | BioAnalytics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | San Francisco, CA | Boston |
| Founded | 1993 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | — | $55M |
| Valuation | — | — |
What They Build
FibroGen
Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.
BioAnalytics
Boston-based biotech company developing analytics and data solutions for the life sciences industry.
Key Investors
FibroGen
BioAnalytics
No investors listed.
Sector Overlap
Both FibroGen and BioAnalytics operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
14-day free trial. No credit card required.